AI Article Synopsis

Article Abstract

Rationale: Candida bloodstream infection continues to be a significant cause of mortality in premature infants. Amphotericin B has been recommended as the primary treatment; however, its use is limited due to drug-induced nephrotoxicity and amphotericin B-resistant candidemia.

Patient Concerns: The gestational age was 29 (+6) weeks, and birth weight was 1760 g.

Diagnosis: The infant was diagnosed with Candida parapsilosis bloodstream infection.

Interventions: Fluconazole, 12 mg/kg/day, combined with caspofungin (loading dose 3 mg/kg, at a maintenance dose of 2 mg/kg every 24 h) therapy was administered to premature infant with Candida bloodstream infection. When fluconazole or caspofungin was used to treat Candida bloodstream infection in preterm infants, the blood cultures of the infant remained positive for Candida parapsilosis.

Outcomes: All persistent candidemia resolved on fluconazole combined with caspofungin therapy. There were no adverse effects, hepatotoxicity, nephrotoxicity, anemia, or thrombocytopenia.

Lessons: Fluconazole combined with caspofungin successfully treated Candida bloodstream infection in premature infants at 29 + 6 weeks' gestational age, but large-scale clinical trials are required.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718204PMC
http://dx.doi.org/10.1097/MD.0000000000028270DOI Listing

Publication Analysis

Top Keywords

candida bloodstream
20
bloodstream infection
20
combined caspofungin
16
fluconazole combined
12
infection preterm
8
premature infants
8
gestational age
8
candida
7
bloodstream
6
caspofungin
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!